Skip to main content

Table 3 Clinical Outcome during in-hospital and 30-day follow-up in diabetic and non-diabetic patients

From: Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions

  

DM

Non-DM

P

Subject number (n)

237

73

164

NA

Composite MACE

35 (14.8)

18 (24.7)

17 (10.4)

0.004

Cardiac death

4 (1.7)

2 (2.7)

2 (1.2)

0.770

Reinfarction

3 (1.3)

2 (2.7)

1 (0.6)

0.469

Repeated TVR

3 (1.3)

1 (1.4)

2 (1.2)

0.594

Recurrent angina

15 (6.3)

9 (12.3)

6 (3.7)

0.025

Malignant arrhythmia

10 (4.2)

5 (6.8)

5 (3)

0.320

Non-cardiac death

1 (0.4)

0 (0)

1 (0.6)

0.678

Non-IRA revascularization

53 (22.4)

27 (37)

26 (16)

0.001

  1. Data given as mean ± SD or n (%).
  2. MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us